Jasper Therapeutics Inc. (NASDAQ:JSPR) trading with a subtraction of -$2.69 to $12.10 on Thursday, a downside of -18.19 percent. An average of 19,159,754 shares of common stock have been traded in the last five days. There was a gain of $3.71 in the past week, and it reached a new high 25 times over the past 12 months. The last 20 days have seen an average of 6,029,264 shares traded, while the 50-day average volume stands at 2,443,525.
JSPR stock has increased by 48.10% in the last month. The company shares reached their 1-month lowest point of $7.11 on 10/12/21. With the stock rallying to its 52-week high on 10/13/21, shares of the company touched a low of $7.11 and a high of $18.24 in 52 weeks. It has reached a new high 16 times so far this year and achieved 47.75% or $2.02 in price. In spite of this, the price is down -33.66% from the 52-week high.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
Jasper Therapeutics Inc. (JSPR) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.77 for the sector. Other valuation ratios to consider include the price-to-book (PB) ratio at 2.14.
The quick ratio of Jasper Therapeutics Inc. for the recent quarter was 1.30, and the current ratio was 1.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the recent quarter.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Jasper Therapeutics Inc.’s return on assets was -4.30%.
From a technical analysis perspective, let’s take a brief look at Jasper Therapeutics Inc. (JSPR) price momentum. RSI 9-day as of the close on 13 October was 57.72%, suggesting the stock is Neutral, with historical volatility in this time frame at 403.53%.
As of today, JSPR’s price is $9.96 +44.65% or $3.71 from its 5-day moving average. JSPR is currently trading +20.23% higher than its 20-day SMA and +21.44% higher than its 100-day SMA. However, the stock’s current price level is +21.13% above the SMA50 and +20.35% above the SMA200.
The stochastic %K and %D were 38.13% and 21.59%, respectively, and the average true range (ATR) was 2.79. With the 14-day stochastic at 44.25% and the average true range at 2.24, the RSI (14) stands at 56.06%. The stock has reached 2.05 on the 9-day MACD Oscillator while the 14-day reading was at 1.56.
Oppenheimer launched coverage on Jasper Therapeutics Inc. (NASDAQ: JSPR) in its analyst report released on October 13, 2021. The firm assigned the stock a an Outperform rating.The consensus rating for Jasper Therapeutics Inc. (JSPR) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell JSPR, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is JSPR’s price target for the next 12 months?
Analysts predict a range of price targets between $21.00 and $21.00, with a median target of $21.00. Taking a look at these predictions, the average price target given by analysts for Jasper Therapeutics Inc. (JSPR) stock is $21.00.